Long Biliopancreatic Limb (BPL) RYGB Versus Short BPL RYGB Post-Suboptimal Initial Clinical Response of SG or Recurrent Weight Gain: A Randomized Controlled Study - Scorecard - MDSpire
Advertisement
Long Biliopancreatic Limb (BPL) RYGB Versus Short BPL RYGB Post-Suboptimal Initial Clinical Response of SG or Recurrent Weight Gain: A Randomized Controlled Study
Clinical Scorecard: Comparison of Long versus Short Biliopancreatic Limb in RYGB Following Inadequate Initial Response to SG or Recurring Weight Regain: A Randomized Controlled Trial
At a Glance
Category
Detail
Condition
Obesity with inadequate response or weight regain after sleeve gastrectomy (SG)
Key Mechanisms
Roux-en-Y gastric bypass (RYGB) with variation in biliopancreatic limb (BPL) length affecting weight loss and metabolic outcomes
Target Population
Patients with obesity who had SG with suboptimal control of response (SoCR), recurring weight regain (RWG), or complicated gastroesophageal reflux disease (GERD)
Care Setting
Metabolic and bariatric surgery centers with multidisciplinary teams
Key Highlights
RYGB is the preferred conversional procedure after SG failure due to SoCR or RWG.
This randomized controlled trial compared long BPL (150 cm) versus short BPL (50–75 cm) in conversional RYGB.
Primary outcomes included weight loss and metabolic profile at 1-year follow-up; secondary outcomes included complications and hospital stay.
Guideline-Based Recommendations
Diagnosis
Identify SoCR as less than 50% excess weight loss (EWL%) over 18–24 months post-SG.
Define RWG as weight gain after initial successful weight loss (EWL >50%).
Assess GERD symptoms pre- and postoperatively using validated questionnaires.
Management
Consider conversional RYGB for patients with SoCR, RWG, or intractable GERD after SG.
Perform RYGB laparoscopically with either long or short biliopancreatic limb lengths based on clinical trial protocols.
Provide routine postoperative care including diet, supplementation, and early mobilization.
Monitoring & Follow-up
Follow patients regularly up to at least 1 year post-surgery to assess EWL%, excess BMI loss (EBMIL%), and metabolic parameters.
Evaluate GERD symptom remission or improvement using symptom scores.
Monitor for surgery-related complications and length of hospital stay.
Risks
Potential for surgical complications inherent to RYGB.
Risk of inadequate weight loss or weight regain if limb lengths are not optimized.
Possibility of worsening or de novo GERD symptoms post-SG requiring conversion.
Patient & Prescribing Data
Adults with obesity post-SG exhibiting SoCR, RWG, or GERD complications
Randomized allocation to long BPL (150 cm) or short BPL (50–75 cm) RYGB showed feasibility and allowed comparison of weight loss and metabolic outcomes at 1 year.
Clinical Best Practices
Use multidisciplinary assessment to confirm fitness for metabolic and bariatric surgery following established guidelines (NIH, ASMBS, IFSO).
Employ validated questionnaires to assess GERD symptoms pre- and postoperatively.
Randomize patients appropriately when comparing surgical techniques to minimize bias.
Ensure standardized calculation of weight loss outcomes (EWL%, EBMIL%) and comorbidity remission per ASMBS standards.
Provide comprehensive postoperative care including early mobilization and nutritional support.
A retrospective database study found a low absolute incidence but higher relative hazard of ischemic optic neuropathy following semaglutide initiation.